331 related articles for article (PubMed ID: 29226826)
1. Prostate Magnetic Resonance Imaging Interpretation Varies Substantially Across Radiologists.
Sonn GA; Fan RE; Ghanouni P; Wang NN; Brooks JD; Loening AM; Daniel BL; To'o KJ; Thong AE; Leppert JT
Eur Urol Focus; 2019 Jul; 5(4):592-599. PubMed ID: 29226826
[TBL] [Abstract][Full Text] [Related]
2. Accuracy and Variability of Prostate Multiparametric Magnetic Resonance Imaging Interpretation Using the Prostate Imaging Reporting and Data System: A Blinded Comparison of Radiologists.
Pickersgill NA; Vetter JM; Andriole GL; Shetty AS; Fowler KJ; Mintz AJ; Siegel CL; Kim EH
Eur Urol Focus; 2020 Mar; 6(2):267-272. PubMed ID: 30327280
[TBL] [Abstract][Full Text] [Related]
3. Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study.
Greer MD; Brown AM; Shih JH; Summers RM; Marko J; Law YM; Sankineni S; George AK; Merino MJ; Pinto PA; Choyke PL; Turkbey B
J Magn Reson Imaging; 2017 Feb; 45(2):579-585. PubMed ID: 27391860
[TBL] [Abstract][Full Text] [Related]
4. Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate.
Kuru TH; Roethke MC; Rieker P; Roth W; Fenchel M; Hohenfellner M; Schlemmer HP; Hadaschik BA
BJU Int; 2013 Dec; 112(8):1080-7. PubMed ID: 23937255
[TBL] [Abstract][Full Text] [Related]
5. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.
Wegelin O; Exterkate L; van der Leest M; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE
Eur Urol; 2019 Apr; 75(4):582-590. PubMed ID: 30522912
[TBL] [Abstract][Full Text] [Related]
6. Quantib Prostate Compared to an Expert Radiologist for the Diagnosis of Prostate Cancer on mpMRI: A Single-Center Preliminary Study.
Faiella E; Vertulli D; Esperto F; Cordelli E; Soda P; Muraca RM; Moramarco LP; Grasso RF; Beomonte Zobel B; Santucci D
Tomography; 2022 Aug; 8(4):2010-2019. PubMed ID: 36006066
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of a computer-aided diagnosis system for determining cancer aggressiveness in prostate MRI.
Litjens GJ; Barentsz JO; Karssemeijer N; Huisman HJ
Eur Radiol; 2015 Nov; 25(11):3187-99. PubMed ID: 26060063
[TBL] [Abstract][Full Text] [Related]
8. Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.
Stabile A; Giganti F; Kasivisvanathan V; Giannarini G; Moore CM; Padhani AR; Panebianco V; Rosenkrantz AB; Salomon G; Turkbey B; Villeirs G; Barentsz JO
Eur Urol Oncol; 2020 Apr; 3(2):145-167. PubMed ID: 32192942
[TBL] [Abstract][Full Text] [Related]
9. Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naïve patients: a retrospective cohort study.
Washino S; Kobayashi S; Okochi T; Kameda T; Konoshi T; Miyagawa T; Takayama T; Morita T
BMC Urol; 2018 May; 18(1):51. PubMed ID: 29843694
[TBL] [Abstract][Full Text] [Related]
10. Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA.
Müller S; Lilleaasen G; Sand TE; Løfsgaard L; Estop-Garanto M; Helgø D; Sund P; Mygland V
World J Urol; 2018 May; 36(5):687-691. PubMed ID: 29508048
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
[TBL] [Abstract][Full Text] [Related]
12. Review of the accuracy of multi-parametric MRI prostate in detecting prostate cancer within a local reporting service.
Tsai WC; Field L; Stewart S; Schultz M
J Med Imaging Radiat Oncol; 2020 Jun; 64(3):379-384. PubMed ID: 32243728
[TBL] [Abstract][Full Text] [Related]
13. In-gantry MRI guided prostate biopsy diagnosis of prostatitis and its relationship with PIRADS V.2 based score.
Jyoti R; Jina NH; Haxhimolla HZ
J Med Imaging Radiat Oncol; 2017 Apr; 61(2):212-215. PubMed ID: 27987276
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
[TBL] [Abstract][Full Text] [Related]
15. Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1.
Brembilla G; Dell'Oglio P; Stabile A; Damascelli A; Brunetti L; Ravelli S; Cristel G; Schiani E; Venturini E; Grippaldi D; Mendola V; Rancoita PMV; Esposito A; Briganti A; Montorsi F; Del Maschio A; De Cobelli F
Eur Radiol; 2020 Jun; 30(6):3383-3392. PubMed ID: 32052171
[TBL] [Abstract][Full Text] [Related]
16. Difference in MRI-guided biopsy cancer detection rates between individual clinicians.
Sathianathen NJ; Warlick CA; Soubra A; Balaji P; Metzger GJ; Spilseth B; Murugan P; Ordonez M; Weight CJ; Konety BR
Urol Oncol; 2019 May; 37(5):299.e1-299.e6. PubMed ID: 30797649
[TBL] [Abstract][Full Text] [Related]
17. Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer with Multiparametric versus Hybrid Multidimensional MRI.
Lee GH; Chatterjee A; Karademir I; Engelmann R; Yousuf A; Giurcanu M; Harmath CB; Karczmar GS; Oto A
Radiology; 2022 Nov; 305(2):399-407. PubMed ID: 35880981
[TBL] [Abstract][Full Text] [Related]
18. Clinical study of multifactorial diagnosis in prostate biopsy.
Li J; Wang K; Li S; Wu P; Wang X; He Y; Tang W
Prostate; 2023 Nov; 83(15):1494-1503. PubMed ID: 37545333
[TBL] [Abstract][Full Text] [Related]
19. Performance of prostate health index and PSA density in a diverse biopsy-naïve cohort with mpMRI for detecting significant prostate cancer.
Carbunaru S; Stinson J; Babajide R; Hollowell CMP; Yang X; Sekosan M; Ferrer K; Kajdacsy-Balla A; Abelleira J; Ruden M; King-Lee P; Dalton DP; Casalino DD; Kittles RA; Gann PH; Schaeffer EM; Murphy AB
BJUI Compass; 2021 Nov; 2(6):370-376. PubMed ID: 35474697
[TBL] [Abstract][Full Text] [Related]
20. The predictive value of the prostate health index vs. multiparametric magnetic resonance imaging for prostate cancer diagnosis in prostate biopsy.
Stejskal J; Adamcová V; Záleský M; Novák V; Čapoun O; Fiala V; Dolejšová O; Sedláčková H; Veselý Š; Zachoval R
World J Urol; 2021 Jun; 39(6):1889-1895. PubMed ID: 32761380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
